ClinicalTrials.gg
CompletedNCT05317897Updated Jan 17, 2025

Utility of Lung Ultrasonography As a Predictor of Fast Track Extubation

An observational study in Exta Vascular Lung Water, sponsored by Kasr El Aini Hospital. Completed at 2 sites in Egypt. Open to participants aged 6 Months to 7 Years. Per ClinicalTrials.gov, last updated 2025-01-17.

Sponsored by Kasr El Aini Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45
Ages
6 Months to 7 Years
Sex
All
01

Study summary

Fast-tracking in cardiac surgery refers to early extubation to reduce costs and perioperative morbidity. The use of lung ultrasound is recently accepted as a tool in the assessment of several lung conditions. The aim of this study was to assess the use of lung ultrasound score as a quantitative method to assist in the decision of early extubation.

Read the detailed description

background: Fast-tracking in cardiac surgery refers to early extubation to reduce costs and perioperative morbidity. The use of lung ultrasound is recently accepted as a tool in the assessment of several lung conditions. The aim of this study was to assess the use of lung ultrasound score as a quantitative method to assist in the decision of early extubation.

Methedology: in this prospective, observational study, 45 pediatric patients who will go elective repair of congenital acyanotic heart diseases were included and were examined with Lung ultrasound together with arterial blood gases preoperative and postoperative and given a score range from 0-3 according to number of B lines in each region and sensitivity of post-operative lung ultrasound score to extubation within 6 hours was examined Demographic data: Patients' name, age, sex, diagnosis, relevant medical and surgical history. And Assessment data: Baseline arterial blood gases and lung ultrasound score assessment after induction of anesthesia and at the end of surgery.

Primary outcome will be the sensitivity of lung ultrasound scores immediately at the end of pediatric cardiac operation in prediction of extubation. and Secondary outcome will be correlation between lung ultrasound score and Po2/Fio2 ratio at the end of operation

02

Conditions studied

  • Exta Vascular Lung Water
03

In context

Lead sponsor

Kasr El Aini Hospital is the lead sponsor of 283 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients suffering from Acyanotic congenital heart diseases.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • were Age 6 months to 7 years
  • Patients suffering from Acyanotic congenital heart diseases.

Exclusion criteria

Exclusion Criteria:

  • Age is less than 6 months and more than 7 years,
  • Preoperative mechanical ventilation,
  • Preoperative inotropic support.,
  • Trisomy 21,
  • Patient with cyanotic heart diseases
  • Coagulopathy INR >1.5
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testLung ultrasound examination

    45 pediatric patients who will go elective repair of congenital acyanotic heart diseases will be included and will be examined with Lung ultrasound together with arterial blood gases preoperative and postoperative and given a score range from 0-3 according to number of B lines in each region and sensitivity of post-operative lung ultrasound score to extubation within 6 hours was examined.

    Also known as: The lung ultrasound score

06

What researchers measure

Primary outcomes

  1. the sensitivity of lung ultrasound scores

    the sensitivity of lung ultrasound scores immediately at the end of pediatric cardiac operation in prediction of extubation

    Time frame: immediately at the end of pediatric cardiac operation

Secondary outcomes

  1. correlation between lung ultrasound score and Po2/Fio2 ratio

    correlation between lung ultrasound score and Po2/Fio2 ratio at the end of operation

    Time frame: immediatly at the end of pediatric cardiac operation until 6 hours post operative until extubatiioon

07

Study locations

2 sites
  • Kasr Al Ainy Hospital
    Cairo, Cairo Governorate 11562, Egypt
  • Kasr Alainy hospital
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2018 to primary completion in Jun 2022, 44 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2022
First posted
Apr 8, 2022
StartActual
Sep 20, 2018
Primary completionActual
Jun 1, 2022
CompletionActual
Aug 1, 2022
Last update
Jan 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05317897
Responsible party
Ahmed Mohamed Mohamed Elhaddad (Lecturer of Anesthesia, ICU and Pain managment, Kasr El Aini Hospital) — Principal investigator
First posted
Apr 8, 2022
Start date
Sep 20, 2018
Primary completion
Jun 1, 2022
Completion
Aug 1, 2022
Last update
Jan 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion